Aduro BioTech

Make payments with PayPal - it's fast, free and secure! Learn about supporting IT History Society
  • 2000

Company Description

Aduro BioTech is a development-stage biopharmaceutical company engaged in the development of early-stage cancer therapies.

Aduro is a clinical-stage cancer immunotherapy company with three products currently in human trials. The company’s lead candidate – an immunotherapy regimen combining their proprietary CRS-207 with GVAX Pancreas – is targeting metastatic pancreatic cancer and has received Breakthrough Therapy designation from the US Food and Drug Administration.

CrunchBase
Edit this page
Add a company to our database